本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Milestone Pharmaceuticals Inc.

1.88
-0.0100-0.53%
盘后1.900.0200+1.06%19:59 EDT
成交量:145.60万
成交额:273.85万
市值:1.60亿
市盈率:-2.24
高:1.93
开:1.91
低:1.86
收:1.89
52周最高:2.75
52周最低:0.6254
股本:8,499.43万
流通股本:7,881.45万
量比:0.88
换手率:1.85%
股息:- -
股息率:- -
每股收益(TTM):-0.8376
每股收益(LYR):-0.6674
净资产收益率:-780.29%
总资产收益率:-50.33%
市净率:-9.00
市盈率(LYR):-2.82

数据加载中...

2023/03/07

重要事件披露

8-K - Current report
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/01/18

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/12/06

重要事件披露

8-K - Current report
2022/11/10

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/11/10

重要事件披露

8-K - Current report
2022/10/31

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/10/24

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/10/17

重要事件披露

8-K - Current report
2022/09/26

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/09/20

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/08/10

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/08/10

重要事件披露

8-K - Current report
2022/07/08

重要事件披露

8-K - Current report
2022/05/12

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/03/24

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans